Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders
Cognitive Function in Leukocyte Disorders
2 other identifiers
observational
150
1 country
1
Brief Summary
This study will try to determine what causes learning, behavioral and emotional problems in children with chronic granulomatous disease (GCD) and other phagocyte disorders. (Phagocytes are a type of white blood cell.) Children with these disorders have frequent severe infections that require hospitalization, sometimes for long periods of time. Many of them also have problems with school, learning, behavior, anxiety and depression. This study will explore whether these latter problems are a direct result of the illness itself or are a consequence of frequent, long hospitalizations, or are due to other factors. Test findings in these children will be compared with those of children with cystic fibrosis-another disease that causes frequent infections requiring prolonged hospitalization. Patients age 2 or older with GCD or other phagocytic disorders or cystic fibrosis may be eligible for this study. Participants (or a parent or guardian) will complete questionnaires including personal information such as age, gender and marital status, a family medical history, and information on their illness. Patients will be given various psychological and intelligence tests, and they and their parents or guardians will be interviewed by a child psychiatrist. The tests and interviews take a total of about 5 hours and are given in two or three separate sessions. The tests may reveal problems such as learning disorders, attention-deficit hyperactivity disorder, anxiety, or depression. If any of these problems are identified, appropriate referrals will be made for specialized services, such as special school placement, tutoring, or counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2000
CompletedFirst Submitted
Initial submission to the registry
July 4, 2000
CompletedFirst Posted
Study publicly available on registry
July 5, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedMarch 4, 2008
July 1, 2005
July 4, 2000
March 3, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Presence of a confirmed diagnosis of CGD or other phagocytic disorder.
- Age 2 or older.
- English spoken in the home.
You may not qualify if:
- Unconfirmed phagocytic disorder.
- Under age 2.
- First language is other than English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, 20892, United States
Related Publications (3)
Batshaw ML. Mental retardation. Pediatr Clin North Am. 1993 Jun;40(3):507-21. doi: 10.1016/s0031-3955(16)38547-9.
PMID: 8493062BACKGROUNDBoyle IR, di Sant'Agnese PA, Sack S, Millican F, Kulczycki LL. Emotional adjustment of adolescents and young adults with cystic fibrosis. J Pediatr. 1976 Feb;88(2):318-26. doi: 10.1016/s0022-3476(76)81011-6.
PMID: 1249700BACKGROUNDEliez S, Reiss AL. Genetics of childhood disorders: XI. Fragile X syndrome. J Am Acad Child Adolesc Psychiatry. 2000 Feb;39(2):264-6. doi: 10.1097/00004583-200002000-00029. No abstract available.
PMID: 10673840BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 4, 2000
First Posted
July 5, 2000
Study Start
June 1, 2000
Study Completion
July 1, 2005
Last Updated
March 4, 2008
Record last verified: 2005-07